BioNTech, moderna, curevac, covid-19, coronavirus, tallaalka:
20200320AD
Bixinnada BTM, iskaashiga dawladda-gaar ahaaneed, Apeiron, SRI International, Iktos, dawooyinka lidka ku ah fayraska, AdaptVac, ExpreS2ion Biotechnologies, pfizer, janssen, sanfi,

Bishii Maarso 16, Guddiga Yurub wuxuu ku dhawaaqay inay ku yabooheen 80 milyan oo Yuuro si ay u taageeraan shirkadda Jarmalka ee CureVac si loo dardar geliyo shaqada tallaalka coronavirus. Macluumaadkani wuxuu u muuqdaa maalin kadib markii ilaha dawladda Jarmalka ay sheegeen in maamulka Donald Trump uu raadinayay qaab uu ku helo marin tallaalkan suurtagalka ah. Taas macnaheedu ma waxaa jira hal shirkad oo shaqeynaya xal u muhiim aadanaha muhiim u ah? WHO (Ururka Caafimaadka Adduunka) ayaa ku daabacda xogta 13 shirkadood oo noocaas ah websaydhkooda, iyo Xogta Xogta ee Caalamiga ah waxay muujineysaa 30 hay'adood oo ka shaqeeya mowduucan. Marka ma jiraan wax fursad ah oo loogu talagalay in si dhaqso leh wax looga qabto dhibaatooyinkeena? Shaydaanka had iyo jeer wuxuu ku jiraa faahfaahinta.
Sida rasmiga ah, waxaa jira hal shirkad oo keliya - American Moderna - oo soo maray marxalad tijaabo caafimaad ah halkaas oo tallaalka lagu tijaabiyey aadanaha. Imtixaannada waxaa lagu sameeyaa Mareykanka gudaheeda Machadka Washington ee Cilmi-baarista Caafimaadka ee Seattle. Horumarinta degdegga ah ee noocan oo kale ah ee tallaalka suurtagalka ah waa mid aan horay loo arag oo ay suurtagal ahayd maxaa yeelay saynisyahannadu waxay u adeegsan karaan khibradaha cudurka 'coronaviruses' ee sababay cudurka faafa ee SARS iyo MERS. In kasta oo ay jirto shaqo duubitaan ah, xitaa haddii tallaalku yahay mid aamin ah oo waxtar u leh fayraska, ma dhici doonto ugu yaraan hal sano.
Dhamaan ciyaartooyda kale ee doonaya inay soo saaraan tallaalka coronavirus waxay hadda ku jiraan marxaladda ugu sarreysa ee tallaalka. Marxaladda saxda ah waa cilmi baaris sheybaarro iyo xayawaanno horseedi kara oo keliya tallaalka qiyaastii hal sano iyo badh. Way adag tahay in la yiraahdo cidda ku guuleysata tartanka tallaalkan, laakiin fursadaha ugu weyn ma ahan kuwa bilaabaya, laakiin waa shirkadaha waaweyn ee daawooyinka.

Shirkadda Jarmalka ee CureVac waxay iskaashi la leedahay hay'ad dowli ah oo fadhigeedu yahay Oslo, waxa loogu yeero Isbahaysiga loogu diyaar garoobayo faafitaanka (CEPI). Waxay ka shaqeynayaan tallaalka ku saleysan mRNA. Sida barnaamijka weyn ee 'Moderna mRNA' ee Mareykanka, CureVac wuxuu doonayaa inuu caddeeyo in tallaallada mRNA la horumarin doono oo la soo saari doono si ka dhaqso badan tallaallada caadiga ah, wuxuuna damacsan yahay inuu aadayo tijaabooyinka caafimaad ee wejiga koowaad horaantii xagaaga.
Sida CureVac - shirkadda Jarmalka ee BioNTech, oo soo saarta tallaallada mRNA ee kansarka iyo ifilada - waa mowduuca iskaashi suurtagal ah lala yeesho shirkadda dawada weyn ee Pfizer si loo soo saaro tallaal ka hortaga fayraska Covid19. Sanofi iyo Janssen waxay iska kaashadaan xafiiska American Biomedical Advanced Office for Research and Development (BARDA) waxayna waliba marayaan marxalad hordhac ah.
Mashaariic badan oo yaryar ayaa sidoo kale socda. Isniintii2 EUR 7 milyan oo kaalmooyin ah oo hoos yimaad barnaamijka Horizon2020 waxaa loo qoondeeyay iskaashatada-gaarka ah ee deenishka: shirkadaha cilmiga bayoolajiga ah ee ExpreS2ion Biotechnologies iyo AdaptVac. Xiriirku wuxuu qorsheynayaa inuu soo saaro wejiga I / IIa tijaabada kiliinikada talaalka 12 bilood gudahood.

In kasta oo tallaallada ugu horreeya laga yaabo inay ku jiraan marxalad hufan illaa xagaaga, hagayaashu waxay u baahan doonaan hal illaa laba sano oo baaritaanka bini-aadamka si loo hubiyo in tallaalku aamin yahay oo waxtar leeyahay. Marka la helo oggolaanshaha ka dib, shirkaduhu waxay bilaabi karaan soo saarista iyo qaybinta tallaalka si baaxad leh ganacsi, oo sidoo kale qaata waqti dheer. Marka la soo koobo, adduunku wuxuu u arkaa talaalka loo yaqaan "Covid-19" oo la ansixiyay kaliya badhtamaha 2121.
Si kastaba ha noqotee, waxaa soo baxday in tallaalku uusan ahayn badbaadada keliya. Shirkado badan ayaa rajeynaya inay horumariyaan dawooyinka cusub ee ka hortaga fayraska ama ay la qabsadaan dawooyinka hadda jira ee tijaabada ah si ay ula dagaallamaan fayraska cusub. Tani waa hawl adag maxaa yeelay, si ka duwan bakteeriyada, fayrasyadu waxay ku dhuuntaan unugyadayada. Taas macnaheedu waa in daawooyinka joojiya fayrasku ay inta badan saameyn ku yeeshaan unugyadayada, kuwaas oo sababi kara waxyeelo.
Shirkadda Parisi ee Iktos ee ka shaqeysa soo saarista daroogada iyada oo loo marayo sirdoonka macmal ayaa bilaabay wada shaqeyn ay la yeelatay shirkadda kiimikada ee Mareykanka SRI International. Ujeeddada iskaashigu waa in la soo saaro dawooyin cusub oo fayraska ka hortaga ah oo loogu talagalay daaweynta Covid19 iyo noocyo kale oo fayras ah. Shirkadda cilmiga bayoolajiga ee Austaralia Apeiron waxay biloowday tijaabadii tijaabada wejiga labaad ee tijaabada daawada murashax ee ka dhanka ah Covid-19 dhamaadka Febraayo. Daawada borotiinka ayaa horeyba u soo gabagabeysey daraasadaha wejiga I iyo II ee daaweynta daweynta dhaawaca sambabka waxaana la rajaynayaa in ay ku shaqeyso is barbar dhig borotiinka kaas oo coronavirus ku xirayo muddadii duulaanka sambabka. Waxa kale oo jira mashaariic badan oo loogu talagalay isbedelka isticmaalka dawooyinka lidka-fayraska ee la ansixiyay daaweynta Covid-19. Tani waxay leedahay faa'iidooyin ah in amniga daroogada mar hore la ogaa oo uu dhaqso ugu gaari karo suuqa. Baarayaasha ka socda Göttingen iyo Berlin, Germany, ayaa hadda baaraya suurtagalnimada kamostat mesylate - oo ah daawo lagu oggolaaday Japan in lagu daweeyo cudurka qaaxada.

http: //www.e-manus.pl/